Profile data is unavailable for this security.
About the company
Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
- Revenue in EUR (TTM)97.95m
- Net income in EUR-70.99m
- Incorporated2005
- Employees486.00
- LocationBiosynex SA22 Boulevard Sebastien BrantILLKIRCH-GRAFFENSTADEN 67400FranceFRA
- Phone+33 388787887
- Fax+33 388787678
- Websitehttps://www.biosynex.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aton SA | -100.00bn | -100.00bn | 4.97m | 9.00 | -- | 11.79 | -- | -- | -- | -- | -- | 0.0005 | -- | -- | -- | -- | -- | -17.95 | -- | -27.45 | -- | -- | -- | -741.48 | 0.3307 | -- | 0.8386 | -- | 0.3268 | 21.18 | 86.01 | -- | -- | -- |
| Spineway SA | 10.99m | -1.90m | 6.20m | 43.00 | -- | 0.2598 | -- | 0.5642 | -0.0488 | -0.0488 | 0.2451 | 0.6713 | 0.3739 | 0.6205 | 3.44 | 224,244.90 | -6.47 | -25.14 | -7.73 | -30.76 | 71.33 | 76.66 | -17.29 | -77.57 | 2.04 | -0.8529 | 0.0607 | -- | 13.60 | 18.95 | 40.63 | -- | -27.97 | -- |
| Carmat SA | 6.97m | -51.40m | 6.36m | 153.00 | -- | -- | -- | 0.9128 | -1.21 | -1.21 | 0.1566 | -0.7708 | 0.146 | 1.40 | 1.48 | 45,549.02 | -107.63 | -80.36 | -152.29 | -100.51 | -338.50 | -- | -737.48 | -2,088.98 | 1.01 | -15.43 | 2.46 | -- | 149.16 | -- | 4.59 | -- | 18.44 | -- |
| Bluelinea SA | 10.26m | -753.92k | 9.21m | 79.00 | -- | 8.91 | 10.11 | 0.8974 | -0.0599 | -0.0599 | 0.8151 | 0.0561 | 1.04 | 0.4744 | 12.49 | 115,324.50 | -7.61 | -21.89 | -25.35 | -51.84 | 98.54 | 94.99 | -7.35 | -23.71 | 0.3257 | -7.62 | 0.8821 | -- | -3.88 | 8.42 | 21.57 | -- | 21.85 | -- |
| Spineguard SA | 4.32m | -2.56m | 11.65m | 15.00 | -- | 1.87 | -- | 2.69 | -0.0459 | -0.0459 | 0.0767 | 0.0664 | 0.4969 | 1.44 | 4.26 | 196,474.10 | -29.46 | -27.72 | -45.24 | -47.39 | 70.98 | 73.78 | -59.29 | -59.20 | 0.8202 | -5.14 | 0.3472 | -- | 7.77 | -7.41 | 26.33 | -- | 10.00 | -- |
| Laboratoires Euromedis SA | 38.40m | -5.48m | 12.65m | 44.00 | -- | 0.7547 | -- | 0.3294 | -1.93 | -1.93 | 13.51 | 5.83 | 0.9009 | 2.76 | 4.01 | 872,683.60 | -12.98 | 8.24 | -17.97 | 11.78 | 26.77 | 32.38 | -14.41 | 6.09 | 2.25 | -16.41 | 0.3414 | -- | 6.39 | -14.02 | -146.59 | -- | -- | -- |
| Intrasense SA | 2.65m | -6.48m | 14.18m | 76.00 | -- | -- | -- | 5.36 | -0.1231 | -0.1231 | 0.0503 | -0.0221 | 0.2982 | -- | 3.27 | 34,815.79 | -73.01 | -38.28 | -205.39 | -56.16 | 64.13 | 85.39 | -244.82 | -85.81 | -- | -116.17 | 6.65 | -- | -32.04 | -7.51 | -58.01 | -- | 29.78 | -- |
| Biosynex SA | 97.95m | -70.99m | 18.94m | 486.00 | -- | 0.4186 | -- | 0.1933 | -4.31 | -4.31 | 6.16 | 2.41 | 0.5469 | 1.27 | 10.61 | 201,549.40 | -39.52 | 7.98 | -73.87 | 10.72 | 58.82 | 52.27 | -72.26 | 8.76 | 0.4506 | -11.46 | 0.5825 | -- | 8.81 | 24.20 | -16.73 | -- | -- | -- |
| Mauna Kea Technologies SA | 7.48m | -10.39m | 24.05m | 61.00 | -- | -- | -- | 3.22 | -0.1407 | -0.1407 | 0.1015 | -0.3689 | 0.4854 | 1.19 | 4.59 | 115,015.40 | -68.47 | -47.72 | -- | -149.19 | 43.20 | 18.06 | -141.06 | -129.39 | 0.1177 | -- | 9.54 | -- | -26.96 | 0.5957 | -179.15 | -- | -31.06 | -- |
| Ikonisys SA | 617.19k | -2.70m | 25.19m | 10.00 | -- | 1.05 | -- | 40.81 | -0.1334 | -0.1334 | 0.0609 | 1.51 | 0.0252 | 0.8103 | 3.40 | 61,719.00 | -11.01 | -- | -14.76 | -- | 0.943 | -- | -437.39 | -- | 0.0691 | -30.68 | 0.1686 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
| Implanet SA | 11.10m | -4.81m | 32.79m | 44.00 | -- | -- | -- | 2.95 | -0.038 | -0.038 | 0.0876 | -0.0108 | 0.7432 | 0.8618 | 5.06 | 253,379.00 | -32.23 | -37.85 | -176.46 | -98.02 | 52.11 | 58.59 | -43.36 | -68.07 | 0.2485 | -- | 1.29 | -- | 26.31 | 4.89 | 21.87 | -- | 25.84 | -- |
| Diagnostic Medical Systems SA | 46.77m | -1.67m | 35.98m | 140.00 | -- | 2.25 | 39.67 | 0.7693 | -0.069 | -0.069 | 2.05 | 0.6006 | 0.876 | 1.84 | 4.52 | 324,798.60 | -2.86 | -11.47 | -5.81 | -20.52 | 39.79 | 38.72 | -3.27 | -14.95 | 0.6154 | -0.5203 | 0.5811 | -- | 9.29 | 8.24 | 70.50 | -- | -- | -- |
| Theraclion SA | 1.90m | -5.25m | 38.29m | 33.00 | -- | -- | -- | 20.12 | -0.1127 | -0.1127 | 0.0408 | -0.0548 | 0.1479 | 0.3304 | 8.74 | 59,455.31 | -40.84 | -33.44 | -55.80 | -47.33 | 54.01 | 66.95 | -276.15 | -360.91 | 1.79 | -67.33 | 2.50 | -- | -54.44 | -21.49 | -56.66 | -- | -4.97 | -- |
Data as of Feb 12 2026. Currency figures normalised to Biosynex SA's reporting currency: Euro EUR
0.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sunny Asset Management SAas of 30 Dec 2025 | 21.44k | 0.11% |
Data from 30 Dec 2025 - 30 Dec 2025Source: FactSet Research Systems Inc.
